Homo sapiens Protein: FAH | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-592595.3 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | FAH | ||||||||||||||||||
Protein Name | fumarylacetoacetate hydrolase (fumarylacetoacetase) | ||||||||||||||||||
Synonyms | |||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000453347 | ||||||||||||||||||
InnateDB Gene | IDBG-25690 (FAH) | ||||||||||||||||||
Protein Structure | |||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | |||||||||||||||||||
Subcellular Localization | |||||||||||||||||||
Disease Associations | Tyrosinemia 1 (TYRSN1) [MIM:276700]: An inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, and hepatorenal manifestations. Typical features include hepatic necrosis, renal tubular injury, episodic weakness, self-mutilation, and seizures. Renal tubular dysfunction is associated with phosphate loss and hypophosphataemic rickets. Progressive liver disease can lead to the development of hepatocellular carcinoma. Dietary treatment with restriction of tyrosine and phenylalanine alleviates the rickets, but liver transplantation has so far been the only definite treatment. {ECO:0000269PubMed:11196105, ECO:0000269PubMed:11476670, ECO:0000269PubMed:1401056, ECO:0000269PubMed:20003495, ECO:0000269PubMed:7550234, ECO:0000269PubMed:7757089, ECO:0000269PubMed:7942842, ECO:0000269PubMed:7977370, ECO:0000269PubMed:8005583, ECO:0000269PubMed:8318997, ECO:0000269PubMed:8364576, ECO:0000269PubMed:8557261, ECO:0000269PubMed:9633815}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | Mainly expressed in liver and kidney. Lower levels are also detected in many other tissues. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 3 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR002529
Fumarylacetoacetase, C-terminal IPR005959 Fumarylacetoacetase IPR011234 Fumarylacetoacetase, C-terminal-related IPR015377 Fumarylacetoacetase, N-terminal |
||||||||||||||||||
PFAM |
PF01557
PF09298 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART | |||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | P16930 | ||||||||||||||||||
PhosphoSite | PhosphoSite-P16930 | ||||||||||||||||||
TrEMBL | Q53XA7 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 2184 | ||||||||||||||||||
UniGene | Hs.73875 | ||||||||||||||||||
RefSeq | NP_000128 | ||||||||||||||||||
HUGO | HGNC:3579 | ||||||||||||||||||
OMIM | 613871 | ||||||||||||||||||
CCDS | CCDS10314 | ||||||||||||||||||
HPRD | 02040 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AC087761 AK313951 BC002527 BT007160 BX537608 CH471136 M55150 X51728 | ||||||||||||||||||
GenPept | AAA52422 AAH02527 AAP35824 BAG36668 CAA36016 CAD97795 EAW99120 EAW99121 | ||||||||||||||||||